Covid-19: NPRA studying use of Sinovac's vaccine for children

By RAGANANTHINI VETHASALAM and FATIMAH ZAINAL

PETALING JAYA: The National Pharmaceutical Regulatory Agency (NPRA) is studying the use of Sinovac's CoronaVac vaccine for the National Covid-19 Immunisation Programme for Children (PICKids).

NPRA director Dr Roshayati Mohd Sani said the dossier was submitted to them last week.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Related stories:
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19 , National Pharmaceutical Regulatory Agency , NPRA , Sinovac , CoronaVac , Vaccine , National Covid-19 Immunisation Programme , Children , PICKids

Next In Nation
Moderate earthquake hits north Molucca Sea
Terengganu fully recovered from floods, all 571 flood victims to return home
Cops foil RM2.8mil cigarette smuggling in Machang
Warisan info chief denies talk of riot, calls for resignation at party convention
Floods: Number of evacuees drops in Pahang, T'ganu
Firearms, ammo seized in drug raid, two arrested
Sabah business group urges unity, cautions against divisive racial politics
National Unity Ministry awaiting full report on Kangkar Pulai temple demolition
Johor exco member expresses regret over demolition of Kangkar Pulai temple
Govt has saved RM800mil with Budi95 programme, says Anwar

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.